首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β‐Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil‐SR Trandolapril Study) Trials

【2h】

Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β‐Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil‐SR Trandolapril Study) Trials

机译：梨中噻嗪类利尿剂/β-受体阻滞剂联合治疗中血压不受控制的遗传变异（抗高血压反应的药物基因组学评估）和INVEST（国际Verapamil-SR Trandolapril研究）试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe majority of hypertensive individuals require combination antihypertensive therapy to achieve adequate blood pressure (BP) control. This study aimed to identify genetic variants associated with uncontrolled BP on combination therapy with a thiazide diuretic and a β‐blocker.

机译：背景大多数高血压患者需要联合降压治疗以实现适当的血压（BP）控制。这项研究旨在鉴定噻嗪类利尿剂和β受体阻滞剂联合治疗与不受控制的BP相关的遗传变异。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
Oyunbileg Magvanjav; Yan Gong; Caitrin W. McDonough; Arlene B. Chapman; Stephen T. Turner; John G. Gums; Kent R. Bailey; Eric Boerwinkle; Amber L. Beitelshees; Toshihiro Tanaka; Michiaki Kubo; Carl J. Pepine; Rhonda M. Cooper‐DeHoff; Julie A. Johnson;
展开▼
作者单位

展开▼
年(卷),期 -1(6),11
年度 -1
页码 e006522
总页数 18
原文格式 PDF
正文语种
中图分类
关键词
combination therapy genomics pharmacogenomics high blood pressure hypertension β‐blockers thiazide diuretics;

机译：联合疗法;基因组学;药物基因组学;高血压;高血压;β受体阻滞剂;噻嗪类利尿剂;

相似文献

外文文献
中文文献
专利

1. Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies [J] . Ana Caroline C. Sá, Amy Webb, Yan Gong, BMC Medical Genomics . 2018,第1期

机译：血压特征基因和对噻嗪类利尿剂的血压反应：PEAR和PEAR-2研究的结果
2. A PHARMACOGENOMIC GENOME-WIDE ASSOCIATION STUDY (GWAS) FOR NEW ONSET DIABETES (NOD) IN THE INTERNATIONAL VERAPAMIL SR-TRANDOLAPRIL STUDY (INVEST) [J] . Chang S., McDonough C. W., Gong Y., Clinical Pharmacology and Therapeutics . 2014,第Suppla1期

机译：国际维拉帕米SR-坦诺拉普利研究（投资）中新发糖尿病（NOD）的药物基因组学全基因组关联研究（GWAS）
3. A PHARMACOGENOMIC GENOME-WIDE ASSOCIATION STUDY (GWAS) FOR NEW ONSET DIABETES (NOD) IN THE INTERNATIONAL VERAPAMIL SR-TRANDOLAPRIL STUDY (INVEST) [J] . Chang S., McDonough C. W., Gong Y., Clinical Pharmacology and Therapeutics . 2014,第Suppla1期

机译：国际维拉帕米SR-坦诺拉普利研究（投资）中新发糖尿病（NOD）的药物基因组学全基因组关联研究（GWAS）
4. Factors Influencing Blood Pressure Response to Trandolapril Add-On Therapy in Patients Taking Verapamil SR (from the International Verapamil SR/Trandolapril INVEST Study) [O] . Martin Brunner, Rhonda M. Cooper-DeHoff, Yan Gong, -1

机译：服用维拉帕米SR的患者对他多拉普利追加疗法的血压反应的影响因素（来自国际维拉帕米SR / Trandolapril INVEST研究）
5. Factors Influencing Blood Pressure Response to Trandolapril Add-On Therapy in Patients Taking Verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study) [O] . Department of Pharmacy Practice, College of Pharmacy, University of Florida, Gainesville, Florida ( host institution ), Brunner, Martin ( UF author ), Cooper-DeHoff, Rhonda M. ( UF author ), 2007

机译：服用维拉帕米SR的患者对他多拉普利追加疗法的血压反应的影响因素（来自国际维拉帕米SR / Trandolapril [INVEST]研究）

Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β‐Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil‐SR Trandolapril Study) Trials

摘要

著录项

相似文献

相关主题

期刊订阅